I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas
Apatinib, also known as YN968D1, is a small-molecule tyrosine kinase inhibitor (TKI) that selectively binds to and inhibits vascular endothelial growth factor receptor 2 (VEGFR-2). This study aims to collect clinical, radiological and histopathology imaging including detailed radiological data, survival data, clinical parameters, molecular pathology and images of HE slices …
vegf
metastasis
neutrophil count
hypertension
postoperative complication
- 0 views
- 19 Feb, 2024